UBE3A - ubiquitin protein ligase E3A Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 101865547
UBE3A Products (22)
| mRNA | Protein | Name |
|---|---|---|
| XM_045397109.1 | XP_045253044.1 | ubiquitin-protein ligase E3A isoform X1 |
| XM_045397113.1 | XP_045253048.1 | ubiquitin-protein ligase E3A isoform X4 |
| XM_015452532.2 | XP_015308018.1 | ubiquitin-protein ligase E3A isoform X9 |
| XM_045397110.1 | XP_045253045.1 | ubiquitin-protein ligase E3A isoform X2 |
| XM_045397106.1 | XP_045253041.1 | ubiquitin-protein ligase E3A isoform X1 |
| XM_045397118.1 | XP_045253053.1 | ubiquitin-protein ligase E3A isoform X6 |
| XM_045397124.1 | XP_045253059.1 | ubiquitin-protein ligase E3A isoform X10 |
| XM_045397107.1 | XP_045253042.1 | ubiquitin-protein ligase E3A isoform X1 |
| XM_045397119.1 | XP_045253054.1 | ubiquitin-protein ligase E3A isoform X7 |
| XM_045397111.1 | XP_045253046.1 | ubiquitin-protein ligase E3A isoform X3 |
| XM_005558945.3 | XP_005559002.1 | ubiquitin-protein ligase E3A isoform X8 |
| XM_045397108.1 | XP_045253043.1 | ubiquitin-protein ligase E3A isoform X1 |
| XM_045397120.1 | XP_045253055.1 | ubiquitin-protein ligase E3A isoform X7 |
| XM_045397112.1 | XP_045253047.1 | ubiquitin-protein ligase E3A isoform X4 |
| XM_005558946.3 | XP_005559003.1 | ubiquitin-protein ligase E3A isoform X9 |
| XM_045397126.1 | XP_045253061.1 | ubiquitin-protein ligase E3A isoform X12 |
| XM_045397122.1 | XP_045253057.1 | ubiquitin-protein ligase E3A isoform X7 |
| XM_045397121.1 | XP_045253056.1 | ubiquitin-protein ligase E3A isoform X7 |
| XM_045397125.1 | XP_045253060.1 | ubiquitin-protein ligase E3A isoform X11 |
| XM_045397117.1 | XP_045253052.1 | ubiquitin-protein ligase E3A isoform X5 |
| XM_045397114.1 | XP_045253049.1 | ubiquitin-protein ligase E3A isoform X4 |
| XM_045397116.1 | XP_045253051.1 | ubiquitin-protein ligase E3A isoform X4 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
ubiquitin-protein ligase E3A |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-177615 | Apazunersen | Inhibitor | / | Phase 3 |
| HY-177615A | Apazunersen sodium | Inhibitor | / | Phase 3 |
| HY-177651 | Obudanersen | Inhibitor | / | Phase 2 |
| HY-177651A | Obudanersen sodium | Inhibitor | / | Phase 2 |
| HY-148130 | Rugonersen | Activator | 98.50% | Phase 1 |
| HY-148130A | Rugonersen sodium | 97.47% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-162683 | (S)-PHA533533 | 98.27% | Unkown | |
| HY-RS15368 | UBE3A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20508 | Ube3a Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27016 | Ube3a Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service